HeartFlow Analysis vs Reveal LINQ Insertable Cardiac Monitor
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, detailed assessment of coronary artery disease (CAD) to evaluate the functional significance of coronary stenoses and quantify plaque burden. This tool is ideal for patients needing a comprehensive understanding of their coronary anatomy and blood flow dynamics from a standard CT scan, helping to guide treatment decisions without immediate recourse to invasive procedures.
View HeartFlow Analysis →Choose Reveal LINQ Insertable Cardiac Monitor if…
Choose Reveal LINQ Insertable Cardiac Monitor if your patient experiences infrequent or paroxysmal symptoms like syncope or palpitations, necessitating long-term, continuous cardiac rhythm monitoring for accurate diagnosis. This implantable device, with its AI-powered algorithms, is best suited for capturing elusive arrhythmias over an extended period, significantly reducing false alerts and enhancing diagnostic yield.
View Reveal LINQ Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact vendor |
| Deployment | Cloud-based (AWS) | Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HeartFlow AnalysisHeartFlow Analysis is non-invasive for the patient and integrates seamlessly into existing radiology workflows for clinicians, requiring no additional patient visits for the analysis itself. In contrast, the Reveal LINQ ICM requires a surgical implantation procedure, which is a more significant patient burden.
Clinical Value
TieBoth tools offer significant and distinct clinical value within cardiology. HeartFlow provides a non-invasive pathway for diagnosing CAD, potentially avoiding invasive procedures, while Reveal LINQ excels at long-term, accurate detection of intermittent arrhythmias that might otherwise be missed. Their value propositions address different critical needs.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis offers greater transparency and clarity regarding its pricing and value proposition, with established Category I CPT codes and published CMS payment rates, facilitating easier financial planning and reimbursement for healthcare providers. The lack of public pricing for the Reveal LINQ ICM makes a direct value comparison challenging.
Enterprise Readiness
HeartFlow AnalysisBoth are FDA cleared, HIPAA compliant, and have BAAs, demonstrating readiness. However, HeartFlow's cloud-based software integrates directly into existing imaging workflows and IT infrastructure (PACS, EMR) without requiring new surgical pathways or specialized device management infrastructure beyond standard CT operations.
Innovation
HeartFlow AnalysisHeartFlow's application of AI and computational fluid dynamics to non-invasively derive functional coronary artery disease information (FFRct) from a CT scan is a more fundamentally disruptive innovation, potentially transforming the diagnostic pathway for CAD. While Reveal LINQ's AI for false alert reduction is valuable, it represents an enhancement to an existing device category.
Support & Docs
HeartFlow AnalysisWhile both offer robust support, HeartFlow's explicit focus on comprehensive program support, including detailed billing and reimbursement assistance, rate negotiation, claims audit, and appeal support, alongside technology integration and educational resources, provides a more holistic partnership for healthcare systems.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Name | HeartFlow Analysis | Reveal LINQ Insertable Cardiac Monitor |
| Company | HeartFlow | Medtronic |
| Description | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting) |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and Reveal LINQ Insertable Cardiac Monitor.